References
Bene MC, Castoldi G, Knapp W et al (1995) Proposals for the immunological classification of acute leukaemias. European Group for the Immunological Characterization of Leukaemias (EGIL).Leukaemia 9:1783–1786
Murray PG, Young LS (2001) Epstein-Barr virus infection: basis of malignancy and potential for therapy. Expert Rev Mol Med 2001:1–20
Jaffe ES Harris NL, Stein H, Vardiman J (2001) World Health Organisation classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. WHO, Geneva, p 111–114, 121–126, 181–184
Komrokji R, Lancet J, Felgar R, Wang N, Bennett JM (2003) Burkitt’s leukaemia with precursor B-cell immunophenotype and atypical morphology (atypical Burkitt’s leukaemia/lymphoma): case report and review of literature. Leuk Res 27:561–566
Hamilton-Dutoit SJ, Raphael M, Audouin J et al (1993) In situ demonstration of Epstein–Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumour morphology and primary site. Blood 82:619–624
Lenoir GM, Preud’homme JL, Bernheim A, Berger R (1982) Correlation between immunoglobulin light chain expression and variant translocation in Burkitt’s lymphoma. Nature 298(5873):474–476
Cogne M, Preud’homme JL (1990) Gene deletions force nonsecretory alpha-chain disease plasma cells to produce membrane-form alpha-chain only. J Immunol 145(8):2455–2458
Acknowledgements
We thank A. Breuer and T. Buhl for technical assistance and S. Merkelbach-Bruse for general advice and review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimomura, A., Lilienfeld-Toal, M.v., Balta, Z. et al. Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia. Ann Hematol 87, 255–256 (2008). https://doi.org/10.1007/s00277-007-0389-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-007-0389-0